Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02703207 · ClinicalTrials.gov registry record · NA

Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

A NA study of Obstructive Sleep Apnea and OSA COPD Overlap Syndrome, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT02703207 is a NA study of Obstructive Sleep Apnea and OSA COPD Overlap Syndrome that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 108 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02703207, a NA study of Obstructive Sleep Apnea and OSA COPD Overlap Syndrome, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

Cognitive dysfunction in the aging Veteran population is a growing health concern in the Veterans Health System. It is not known whether OSA coexisting with COPD will enhance the risk for cognitive dysfunction. The investigators sought to investigate whether these two highly prevalent diseases, that often co-exist as the 'Overlap Syndrome', combine to enhance cognitive impairment in the elderly Veteran population. Thus, the investigators will study whether elderly patients with Overlap syndrome have increased cognitive deficits compared with OSA or COPD alone. Additionally, treatment of OSA with positive airway pressure (PAP) has been shown to improve neurocognitive function in moderate-to-severe OSA while cognitive decline in COPD may be reversible through treatment with long-term oxygen therapy. The investigators will also study whether treatment with positive airway pressure (PAP) and supplemental oxygen vs PAP alone will improve cognitive function and improve quality of life of elderly Veterans.

Interventions

  • DEVICE Positive airway pressure
  • DEVICE NIPPV and /or oxygen

Study Locations (1)

Michigan

  • John D. Dingell VA Medical Center, Detroit, MI - Detroit

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2016-08-17
Est. Completion 2026-12-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT02703207

The ClinicalTrials.gov registry entry for NCT02703207 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (51% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Positive airway pressure is the first listed.

NCT02703207 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02703207 about?

NCT02703207 is a clinical study titled "Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD". Cognitive dysfunction in the aging Veteran population is a growing health concern in the Veterans Health System. It is not known whether OSA coexisting with COPD will enhance the risk for cognitive dysfunction. The investigators sought to investigate whether these two highly prevalent diseases, that...

What is the current status of trial NCT02703207?

This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2016-08-17. Estimated completion is 2026-12-31.

What conditions does trial NCT02703207 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, OSA COPD Overlap Syndrome.

What interventions are being tested in trial NCT02703207?

The interventions under investigation include: Positive airway pressure (DEVICE), NIPPV and /or oxygen (DEVICE).

Who is sponsoring clinical trial NCT02703207?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02703207 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.